Charles Albright

2017

In 2017, Charles Albright earned a total compensation of $1.3M as Chief Scientific Officer at Editas Medicine, a 53% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$113,498
Option Awards$765,513
Salary$379,275
Other$8,349
Total$1,266,635

Albright received $765.5K in option awards, accounting for 60% of the total pay in 2017.

Albright also received $113.5K in non-equity incentive plan, $379.3K in salary and $8.3K in other compensation.

Rankings

In 2017, Charles Albright's compensation ranked 7,834th out of 14,666 executives tracked by ExecPay. In other words, Albright earned more than 46.6% of executives.

ClassificationRankingPercentile
All
7,834
out of 14,666
47th
Division
Manufacturing
2,938
out of 5,768
49th
Major group
Chemicals And Allied Products
956
out of 2,074
54th
Industry group
Drugs
743
out of 1,730
57th
Industry
Biological Products, Except Diagnostic Substances
139
out of 316
56th
Source: SEC filing on April 26, 2019.

Albright's colleagues

We found three more compensation records of executives who worked with Charles Albright at Editas Medicine in 2017.

2017

Katrine Bosley

Editas Medicine

Chief Executive Officer

2017

Andrew Hack

Editas Medicine

Chief Financial Officer

2017

Gerald Cox

Editas Medicine

Chief Medical Officer

News

In-depth

You may also like